Clinical Trial Update: Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes [EARLY_Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating an allogeneic anti-CD7 CAR-T therapy for Type 1 diabetes mellitus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Allogeneic Anti-CD7 CAR-T

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: T1DM - Type 1 Diabetes Mellitus | EARLY_Phase 1 | Status: RECRUITING